XFOR
X4 Pharmaceuticals Inc
NASDAQ: XFOR · HEALTHCARE · BIOTECHNOLOGY
$4.07
-0.73% today
Updated 2026-04-30
Market cap
$374.59M
P/E ratio
—
P/S ratio
10.67x
EPS (TTM)
$-1.87
Dividend yield
—
52W range
$1 – $5
Volume
0.5M
X4 Pharmaceuticals Inc (XFOR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $3.50M | $3.00M | $3.00M | $0.00 | $0.00 | $0.00 | $2.56M | $35.11M |
| Revenue growth (YoY) | — | — | — | — | -14.3% | +0.0% | -100.0% | — | — | — | +1273.2% |
| Cost of revenue | $400000.00 | $300000.00 | $195000.00 | $103000.00 | $672000.00 | $1.23M | $1.89M | $1.99M | $2.00M | $797000.00 | $6.26M |
| Gross profit | $-400000.00 | $-300000.00 | $-195000.00 | $-103000.00 | $-672000.00 | $3.00M | $-1.89M | $-1.99M | $-2.00M | $1.76M | $28.86M |
| Gross margin | — | — | — | -2.9% | -22.4% | 100.0% | — | — | — | 68.8% | 82.2% |
| R&D | $12.71M | $17.83M | $28.13M | $20.35M | $30.16M | $41.93M | $48.76M | $61.06M | $72.02M | $81.64M | $72.72M |
| SG&A | $2.12M | $6.51M | $8.01M | $18.41M | $17.64M | $20.94M | $24.70M | $27.02M | $32.14M | $61.52M | $43.52M |
| Operating income | $-14.82M | $-24.35M | $-36.13M | $-29.09M | $-46.80M | $-59.87M | $-75.35M | $-87.57M | $-107.52M | $-36.40M | $-86.88M |
| Operating margin | — | — | — | -831.0% | -1560.1% | -1995.8% | — | — | — | -1423.6% | -247.4% |
| EBITDA | $-14.43M | $-24.05M | $-35.94M | $-28.98M | $-46.13M | $-59.52M | $-73.46M | $-89.33M | $-94.89M | $-27.58M | $-85.61M |
| EBITDA margin | — | — | — | -828.1% | -1537.7% | -1984.1% | — | — | — | -1078.5% | -243.8% |
| EBIT | $-14.82M | $-24.35M | $-36.13M | $-29.09M | $-46.80M | $-59.87M | $-75.35M | $-89.85M | $-95.31M | $-28.37M | $-86.88M |
| Interest expense | $472000.00 | $2.52M | $2.08M | $720000.00 | $2.15M | $2.69M | $3.64M | $3.99M | $5.78M | $8.77M | $8.88M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13.22M | $-22.98M | $-33.88M | $-33.28M | $-52.81M | $-62.13M | $-88.70M | $-93.87M | $-101.17M | $-37.45M | $-79.20M |
| Net income growth (YoY) | — | -73.8% | -47.5% | +1.7% | -58.7% | -17.7% | -42.8% | -5.8% | -7.8% | +63.0% | -111.5% |
| Profit margin | — | — | — | -951.0% | -1760.2% | -2071.0% | — | — | — | -1464.6% | -225.6% |